Stock PTLF PETLIFE PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Petlife Pharmaceuticals, Inc.

Equities

PTLF

US71639C1036

Market Closed - OTC Markets
Other stock markets
 15:44:51 2024-05-15 EDT 		5-day change 1st Jan Change
0.0001 USD 0.00% Intraday chart for Petlife Pharmaceuticals, Inc. 0.00% 0.00%
2020 Petlife Pharmaceuticals, Inc. Announces Management Changes CI
2018 Petlife Pharmaceuticals, Inc. Announces Management Changes CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PETLIFE PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
PETLIFE PHARMACEUTICALS, INC. : Completion of Acquisition or Disposition of Assets (form 8-K)
AQ
Petlife Pharmaceuticals, Inc. Announces Management Changes
CI
Petlife Pharmaceuticals, Inc. Announces Management Changes
CI
Petlife Pharmaceuticals, Inc. Announces Management Changes
CI
Petlife Pharmaceuticals, Inc. cancelled the transaction announced on June 22, 2016
CI
Petlife Pharmaceuticals, Inc. Announces Resignation of Geoffrey Broderick as President
CI
Petlife Pharmaceuticals, Inc. Appoints Geoffrey Broderick as President
CI
PetLife Pharmaceuticals, Inc. Announces Addition of Vyvyan Campbell to the Board of Directors
CI
PetLife Pharmaceuticals, Inc. Expands Cell Line Study with InnoVision Therapeutics in Preparation for FDA/CVM Registration Submission
CI
Petlife Pharmaceuticals, Inc. will Change its Ticker to PTLFD from PTLF
CI
PetLife Pharmaceuticals Announces Pre-INAD (Investigational New Animal Drug) Cell Lines Study of Vitalzul™
CI
PetLife Pharmaceuticals, Inc. Signs Contract with InnoVision Therapeutics
CI
Petlife Pharmaceuticals, Inc. Announces Management Appointments
CI
Petlife Pharmaceuticals, Inc. announced that it expects to receive $4 million in funding
CI
Petlife Pharmaceuticals, Inc. Appoints Ralph T. Salvagno to its Board of Directors and as the Chairman of the Board of Directors
CI
Petlife Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt
CI
Petlife Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt
CI
Petlife Pharmaceuticals, Inc. Appoints Sebastian Serrell-Watts as Executive Vice President and Secretary of the Company
CI
Petlife Pharmaceuticals, Inc. announced that it expects to receive $5 million in funding.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTLF Stock
  4. News Petlife Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW